L. Orgiano

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

Anna Maria Di Giacomo, Paolo A. Ascierto, Paola Queirolo et al. · Annals of Oncology · 2014 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17

Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma

Gaia Barisione, Marina Fabbi, Alice Gino et al. · JAMA Ophthalmology · 2015 · 55 citations

Medicine, Cancer Biology, Molecular Medicine +16

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

Rosa Sottile, Pradeepa Pangigadde, Thomas Tan et al. · European Journal of Immunology · 2015 · 38 citations · Full text

Medicine, Immunology, Oncology +15

The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience

L. Orgiano, Fabiana Pani, Giorgio Astara et al. · Supportive Care in Cancer · 2016 · 13 citations

Medicine, Oncology, Surgery +13